Four posters featuring TILT technology were presented at the 13th Cancer Immunotherapy Annual Meeting in Mainz, Germany in May 2015
Enhancement of melanoma adoptive T-cell therapy by adenoviral gene transfer
Enhancing adoptive T-cell therapy with oncolytic adenovirus encoding CD40-ligand
Abscopal effect seen with T-cell therapy enhancing oncolytic adenoviruses armed with TNFa and IL-2